BioCentury
ARTICLE | Clinical News

Corlux mifepristone: Additional Phase III data

January 17, 2011 8:00 AM UTC

Corcept Therapeutics Inc. (NASDAQ:CORT), Menlo Park, Calif. Product: Corlux mifepristone Business: Other Molecular target: Progesterone receptor; Cortisol receptor GR-2 Description: Progesterone an...